We have prepared and evaluated the physico-chemical and biological properties of four different hyaluronated mesoporous silica nanoparticles (MSNs) samples (MSN/HA). Hyaluronic acid (HA) with two different molecular weights (200 and 6.4 kDa) was used for the conjugation of aminopropyl-functionalized MSN (NH2-MSN), following two different procedures. Namely, samples HA200A and HA6.4A were prepared by reacting activated HA with NH2-MSN (method A), while samples HA200B and HA6.4B were obtained carrying out HA activation in the presence of the nanoparticles (method B). The four samples showed similar hydrophilicity, but clear differences in the HA loading, textural properties, surface charge and stability of the suspensions. More in detail, con...
Mesoprous silica nanoparticles (MSNPs) are commonly used in the area of drug delivery due to their h...
WOS: 000452021100003After the introduction of first generation MSNs for drug delivery with some chal...
A facile strategy is presented to synthesize hyaluronic acid (HA) and a fluorescein isothiocyanate (...
In this paper, we present a facile strategy to synthesize hyaluronic acid (HA) conjugated mesoporous...
Mesoporous silica nanoparticles (MSNs) were functionalized with amino groups (MSN-NH2) and then with...
Present cancer treatments using chemotherapy are limited owing to both significant side effects to n...
Mesoporous silica nanoparticles (MSNs), based on the MCM-41 matrix, were functionalized with amino g...
Mesoporous silica nanoparticles (MSNs) were functionalized with amino groups (MSN-NH2) and then with...
Nanoparticle-based drug delivery systems are among the most popular research topics in recent years....
Mesoporous silica nanoparticles (MSNs) have attracted substantial attention for their application in...
Systemic administration of mesoporous silica nanoparticles (MSNs) in biomedical applications has rec...
A large amount of emphasis has been dedicated in recent years to introduce nanoparticles as a viable...
Mesoporous silica nanoparticles (MSNs), based on the MCM-41 matrix, were functionalized with amino g...
Systemic administration of mesoporous silica nanoparticles (MSNs) in biomedical applications has rec...
Here we aimed to correlate different molecular weights of hyaluronic acid (HA), 200, 800 and 1437 kD...
Mesoprous silica nanoparticles (MSNPs) are commonly used in the area of drug delivery due to their h...
WOS: 000452021100003After the introduction of first generation MSNs for drug delivery with some chal...
A facile strategy is presented to synthesize hyaluronic acid (HA) and a fluorescein isothiocyanate (...
In this paper, we present a facile strategy to synthesize hyaluronic acid (HA) conjugated mesoporous...
Mesoporous silica nanoparticles (MSNs) were functionalized with amino groups (MSN-NH2) and then with...
Present cancer treatments using chemotherapy are limited owing to both significant side effects to n...
Mesoporous silica nanoparticles (MSNs), based on the MCM-41 matrix, were functionalized with amino g...
Mesoporous silica nanoparticles (MSNs) were functionalized with amino groups (MSN-NH2) and then with...
Nanoparticle-based drug delivery systems are among the most popular research topics in recent years....
Mesoporous silica nanoparticles (MSNs) have attracted substantial attention for their application in...
Systemic administration of mesoporous silica nanoparticles (MSNs) in biomedical applications has rec...
A large amount of emphasis has been dedicated in recent years to introduce nanoparticles as a viable...
Mesoporous silica nanoparticles (MSNs), based on the MCM-41 matrix, were functionalized with amino g...
Systemic administration of mesoporous silica nanoparticles (MSNs) in biomedical applications has rec...
Here we aimed to correlate different molecular weights of hyaluronic acid (HA), 200, 800 and 1437 kD...
Mesoprous silica nanoparticles (MSNPs) are commonly used in the area of drug delivery due to their h...
WOS: 000452021100003After the introduction of first generation MSNs for drug delivery with some chal...
A facile strategy is presented to synthesize hyaluronic acid (HA) and a fluorescein isothiocyanate (...